Medical Properties Trust Inc DRC (M2PW34)

B3


	Symbol		Exchange		Currency
	M2PW34		B3		BRL	Delayed
	MPW		NYSE		USD	Real-time
	M3P		TradeGate		EUR	Delayed

Currency in BRL

Disclaimer

16.98

+3.33(+24.40%)

Closed11/10

Fair Value

Day's Range

13.37

16.98

52 wk Range

6.93

17.97

M2PW34 Income Statement

Featured here, the Income Statement (earnings report) for Medical Properties Trust Inc DRC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

870.25

1,269.66

1,573.16

1,583.65

885.77

Total Revenues Growth

+8.96%

+45.9%

+23.9%

+0.67%

-44.07%

Cost Of Revenues

23.99

24.89

39.1

45.7

41.57

Gross Profit

846.26

1,244.77

1,534.06

1,537.95

844.2

Gross Profit Growth

+7.2%

+47.09%

+23.24%

+0.25%

-45.11%

Gross Profit Margin %

97.24%

98.04%

97.51%

97.11%

95.31%

Other Operating Expenses, Total

248.72

395.91

466.89

493.47

748.95

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+16.18%	+59.18%	+17.93%	+5.69%	+51.77%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	96.41	131.66	145.64	160.49	145.59
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

597.53

848.86

1,067.17

1,044.48

95.25

Operating Income Growth

+3.85%

+42.06%

+25.72%

-2.13%

-90.88%

EBIT Margin %

68.66%

66.86%

67.84%

65.95%

10.75%

Net Interest Expenses

-237.83

-328.73

-367.39

-359.04

-411.17

Net Interest Expenses Growth

-6.52%

-38.22%

-11.76%

+2.27%

-14.52%

Interest Expense, Total

-237.83

-328.73

-367.39

-359.04

-411.17

Interest And Investment Income

-

-

-

-

-

Other Non Operating Expenses, Total

-0.35

-6.78

45.7

-2.66

-21.41

EBT, Excl. Unusual Items

359.36

513.35

745.48

682.79

-337.33

Gain (Loss) On Sale Of Assets

41.56

-2.83

52.47

536.76

-1.82

Other Unusual Items, Total

-27.14

-47.19

-67.06

-277.83

-392.62

EBT, Incl. Unusual Items

373.78

463.33

730.89

959.72

-686.77

EBT, Incl. Unusual Items Growth

-63.33%

+23.96%

+57.75%

+31.31%

-171.56%

EBT, Incl. Unusual Items Margin

42.95%

36.49%

46.46%

60.6%

-77.53%

Income Tax Expense

-2.62

31.06

73.95

55.9

-130.68

Net Income to Company

376.4

432.27

656.94

903.82

-556.09

Minority Interest

-1.72

-0.82

-0.92

-1.22

-0.38

Net Income

374.68

431.45

656.02

902.6

-556.48

Net Income Growth

-63.15%

+15.15%

+52.05%

+37.59%

-161.65%

Net Income Margin %

43.05%

33.98%

41.7%

56.99%

-62.82%

Preferred Dividend and Other Adjustments

2.31

2.11

2.16

1.6

1.64

Net Income to Common Excl. Extra Items

372.38

429.35

653.86

901

-558.12

Basic EPS - Continuing Operations

0.87

0.81

1.11

1.51

-0.93

Basic EPS - Continuing Operations Growth

-68.55%

-6.96%

+36.88%

+35.54%

-161.96%

Diluted EPS - Continuing Operations

0.87

0.81

1.11

1.5

-0.93

Diluted EPS - Continuing Operations Growth

-68.48%

-6.9%

+37.04%

+35.14%

-162.17%

Basic Weighted Average Shares Outstanding

427.08

529.24

588.82

598.63

598.52

Diluted Weighted Average Shares Outstanding

428.3

530.46

590.14

598.84

598.52

Dividend Per Share

1.02

1.08

1.12

1.16

0.88

Dividend Per Share Growth

+2%

+5.88%

+3.7%

+3.57%

-24.14%

EBITDA

754.11

1,124.81

1,400.95

1,390.06

425.38

EBITDA Growth

+5.2%

+49.16%

+24.55%

-0.78%

-69.4%

EBITDA Margin %

86.65%

88.59%

89.05%

87.78%

48.02%

EBIT